These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 34802543)

  • 21. [Clinical and genetic features of MDS associated with VEXAS syndrome].
    Kunimoto H
    Rinsho Ketsueki; 2024; 65(4):255-264. PubMed ID: 38684436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
    Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
    Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.
    Padureanu V; Marinaș CM; Bobirca A; Padureanu R; Patrascu S; Dascalu AM; Bobirca F; Tribus L; Alexandru C; Serboiu C; Dumitrascu C; Musetescu A
    Cureus; 2024 Jan; 16(1):e53041. PubMed ID: 38410307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern.
    Iannone C; Pellico MR; Campochiaro C; Tescaro L; Zompatori M; Caminati A; Harari S; Caporali R
    Reumatismo; 2024 Jun; 76(2):. PubMed ID: 38916169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome.
    Lecoeuvre H; Le Gall F; Le Naoures C; Vignon-Pennamen MD; Lamaison C; Kammerer-Jacquet SF; Lescoat A; Oger E; Pastoret C; Dupuy A
    Clin Exp Dermatol; 2024 Jul; 49(8):825-833. PubMed ID: 38366665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEXAS Syndrome: A Novelty in MDS Landscape.
    Templé M; Kosmider O
    Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEXAS Syndrome-Review.
    Zhang Y; Dong X; Wang H
    Glob Med Genet; 2023 Sep; 10(3):133-143. PubMed ID: 37501758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.
    Lötscher F; Seitz L; Simeunovic H; Sarbu AC; Porret NA; Feldmeyer L; Borradori L; Bonadies N; Maurer B
    Front Immunol; 2021; 12():800149. PubMed ID: 35126364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist.
    Sterling D; Duncan ME; Philippidou M; Salisbury JR; Kulasekararaj AG; Basu TN
    J Am Acad Dermatol; 2023 Dec; 89(6):1209-1214. PubMed ID: 35121074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman disease.
    Philip R; Cadro V; Aouba A; Chantepie S; Bracquemart C; Dumont A
    Joint Bone Spine; 2024 Jul; 91(4):105731. PubMed ID: 38583690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome.
    Staels F; Betrains A; Woei-A-Jin FJSH; Boeckx N; Beckers M; Bervoets A; Willemsen M; Neerinckx B; Humblet-Baron S; Blockmans DE; Vanderschueren S; Schrijvers R
    Front Immunol; 2021; 12():678927. PubMed ID: 34046042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case report: diagnosis of VEXAS syndrome in a patient with therapy-resistant large vessel vasculitis.
    Boret M; Malfait T
    Acta Clin Belg; 2024 Apr; 79(2):143-147. PubMed ID: 38314661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS.
    Wu Z; Gao S; Gao Q; Patel BA; Groarke EM; Feng X; Manley AL; Li H; Ospina Cardona D; Kajigaya S; Alemu L; Quinones Raffo D; Ombrello AK; Ferrada MA; Grayson PC; Calvo KR; Kastner DL; Beck DB; Young NS
    Cell Rep Med; 2023 Aug; 4(8):101160. PubMed ID: 37586319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic mutations in VEXAS Syndrome and Erdheim-Chester disease: Inflammatory myeloid diseases.
    Alcedo PE; Gutierrez-Rodrigues F; Patel BA
    Semin Hematol; 2022 Jul; 59(3):156-166. PubMed ID: 36115693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [VEXAS syndrome].
    Zeeck M; Kötter I; Krusche M
    Z Rheumatol; 2022 Nov; 81(9):782-786. PubMed ID: 35179640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
    Huang H; Zhang W; Cai W; Liu J; Wang H; Qin T; Xu Z; Li B; Qu S; Pan L; Huang G; Gale RP; Xiao Z
    Exp Hematol Oncol; 2021 Mar; 10(1):23. PubMed ID: 33741056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [VEXAS syndrome : when do we have to consider it ?].
    Coattrenec Y; De Lorenzi C; Samii K; Serratrice J; Seebach JD
    Rev Med Suisse; 2022 Apr; 18(776):652-659. PubMed ID: 35385616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
    Comont T; Heiblig M; Rivière E; Terriou L; Rossignol J; Bouscary D; Rieu V; Le Guenno G; Mathian A; Aouba A; Vinit J; Dion J; Kosmider O; Terrier B; Georgin-Lavialle S; Fenaux P; Mekinian A;
    Br J Haematol; 2022 Feb; 196(4):969-974. PubMed ID: 34651299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEXAS syndrome: An update.
    Khitri MY; Hadjadj J; Mekinian A; Jachiet V
    Joint Bone Spine; 2024 Jul; 91(4):105700. PubMed ID: 38307404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome.
    Lacombe V; Beucher A; Urbanski G; Le Corre Y; Cottin L; Croué A; Bouvier A
    Exp Hematol Oncol; 2022 Feb; 11(1):6. PubMed ID: 35172893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.